Overview

Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer

Status:
Unknown status
Trial end date:
2018-12-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of apatinib in patient with TNBC
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Treatments:
Albumin-Bound Paclitaxel
Apatinib
Paclitaxel